Pratia Teams with VirTrial to Become ‘Virtual Trial Capable’

Article

Applied Clinical Trials

VirTrial has announced an alliance with Pratia, the network of clinical research centers in Europe. All Pratia research centers have completed VirTrial’s Virtual Trial Capable training, making them trained and certified as Virtual Trial Capable and prepared to conduct decentralized clinical trials (DCT).

The training program includes four modules that clinical research professionals complete to demonstrate a level of competence in general telemedicine etiquette and guidelines, as well as how to utilize the VirTrial platform. Participants then receive a Virtual Trial Capable certificate and badge to highlight to sponsors and CROs that they are prepared to conduct hybrid decentralized clinical trials.

“Pratia’s mission is to facilitate access to healthcare to improve the quality of life and the sense of security of our patients. Embracing telehealth technologies that enable a larger patient population to participate supports our goal and we’re proud to be the first network in Europe to offer this benefit to sponsors,” said Małgorzata Gerjatowicz-Osmańska, Managing Director of Pratia. “Our network is expanding across Europe and we plan to maintain our 100% Virtual Trial Capable status with VirTrial to best serve our patients and pharma sponsors.”

Amanda Rangel, VP of Business Development for VirTrial, remarked, “VirTrial is honored to collaborate with forward-thinking sites like those in the Pratia network that are taking action to move the industry forward and improve patient access to clinical trials. The innovative VirTrial telehealth platform was developed by clinical research professionals and we are committed to continued collaboration with sites and supporting site sustainability in the new era of hybrid decentralized trials.”

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.